GY

Gandhi Yalamanchili

Active Director Director DIN 10093155
DIN 10093155 First appointment Mar 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Gandhi Yalamanchili

Data last updated:

Gandhi Yalamanchili is a Director at Ymco Pharmaceuticals Private Limited (since 2023). The company operates in Paper.

DIN 10093155
Primary Designation Director
Industry Paper
First Appointment 29 Mar 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ymco Pharmaceuticals Private Limited U21009AP2023PTC110650
Director29 Mar 20232023Active

Board colleagues of Gandhi Yalamanchili

NameDINCompanyDesignation
Sekunthala Marupudi10093154Ymco Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ymco Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Gandhi Yalamanchili

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gandhi Yalamanchili

Gandhi Yalamanchili currently holds 1 directorship: Ymco Pharmaceuticals Private Limited (Director, since 29 Mar 2023).

Gandhi Yalamanchili was first appointed on 29 Mar 2023 as Director at Ymco Pharmaceuticals Private Limited.

The current boards of Gandhi Yalamanchili's companies include Sekunthala Marupudi (Ymco Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available